Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome

Journal of Controlled Release

Volumn 100, Issue 1, 2004, Pages 41-52

  Maeda, Noriyuki ^a,b   Takeuchi, Yoshito ^a   Takada, Miki ^a   Sadzuka, Yasuyuki ^a   Namba, Yukihiro ^b   Oku, Naoto ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b Nippon Fine Chemical Co Ltd   (Japan)

Author keywords

Angiogenesis; Anti neovascular therapy; Liposome; Polyethylene glycol

Indexed keywords

ANGIOGENIC SITES; ANTI-CANCER DRUGS; ANTI-NEOVASCULAR THERAPY; LIPOSOMES;

ANTIBIOTICS; CELLS; DRUG DOSAGE; ONCOLOGY; POLYETHYLENE GLYCOLS; POLYPEPTIDES;

TUMORS;

ALANYLPROLYLARGINYLPROLYLGLYCINE; ANGIOGENESIS INHIBITOR; DISTEAROYLPHOSPHATIDYLETHANOLAMINE; DOXORUBICIN; GLYCEROPHOSPHOLIPID; LIPOSOME; PEPTIDE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; COLON CARCINOMA; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CONJUGATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MALE; MICROENCAPSULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TARGET ORGAN; TUMOR VASCULARIZATION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ANGIOGENESIS INHIBITORS; ANIMALS; DOXORUBICIN; DRUG CARRIERS; HUMANS; LIPOSOMES; MICE; NEOPLASMS, EXPERIMENTAL; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 7444226268     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2004.07.033     Document Type: Article

References (24)

1. J. Folkman, and P.A. D'Amore Blood vessel formation: what is its molecular basis? Cell 87 7 1996 1153 1155
2. M.S. O'Reilly, L. Holmgren, C. Chen, and J. Folkman Angiostatin induces and sustains dormancy of human primary tumors in mice Nat. Med. 2 6 1996 689 692
3. T. Browder, C.E. Butterfield, B.M. Kraling, B. Shi, B. Marshall, M.S. O'Reilly, and J. Folkman Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer Cancer Res. 60 7 2000 1878 1886
4. N. Oku, T. Asai, K. Watanabe, K. Kuromi, M. Nagatsuka, K. Kurohane, H. Kikkawa, K. Ogino, M. Tanaka, D. Ishikawa, H. Tsukada, M. Momose, J. Nakayama, and T. Taki Anti-neovascular therapy using novel peptides homing to angiogenic vessels Oncogene 21 17 2002 2662 2669
5. T. Asai, K. Shimizu, M. Kondo, K. Kuromi, K. Watanabe, K. Ogino, T. Taki, S. Shuto, A. Matsuda, and N. Oku Anti-neovascular therapy by liposomal DPP-CNDAC targeted to angiogenic vessels FEBS Lett. 520 1-3 2002 167 170
6. T. Sakakibara, F.A. Chen, H. Kida, K. Kunieda, R.E. Cuenca, F.J. Martin, and R.B. Bankert Doxorubicin encapsulated in sterically stabilized liposomes is superior to free drug or drug-containing conventional liposomes at suppressing growth and metastases of human lung tumor xenografts Cancer Res. 56 16 1996 3743 3746
7. D.D. Lasic Doxorubicin in sterically stabilized liposomes Nature 380 6574 1996 561 562
8. Y. Matsumura, and H. Maeda A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS Cancer Res. 46 12 Pt. 1 1986 6387 6392
9. F. Muggia Doxorubicin-polymer conjugates: further demonstration of the concept of enhanced permeability and retention Clin. Cancer Res. 5 1 1999 7 8
10. N. Maeda, Y. Takeuchi, M. Takada, Y. Namba, and N. Oku Synthesis of angiogenesis-targeted peptide and hydrophobized polyethylene glycol conjugate Bioorg. Med. Chem. Lett. 14 4 2004 1015 1017
11. N. Oku, K. Doi, Y. Namba, and S. Okada Therapeutic effect of adriamycin encapsulated in long-circulating liposomes on Meth-A-Sarcoma-bearing mice Int. J. Cancer 58 3 1994 415 419
12. T.M. Allen Liposomal drug formulations. Rationale for development and what we can expect for the future Drugs 56 5 1998 747 756
13. N. Oku, Y. Tokudome, T. Asai, and H. Tsukada Evaluation of drug targeting strategies and liposomal trafficking Curr. Pharm. Des. 6 16 2000 1669 1691
14. K. Maruyama PEG immunoliposome Biosci. Rep. 22 2 2002 251 266
15. C. Brignole, D. Marimpietri, C. Gambini, T.M. Allen, M. Ponzoni, and F. Pastorino Development of Fab′ fragments of anti-GD(2) immunoliposomes entrapping doxorubicin for experimental therapy of human neuroblastoma Cancer Lett. 197 1-2 2003 199 204
16. F. Pastorino, C. Brignole, D. Marimpietri, P. Sapra, E.H. Moase, T.M. Allen, and M. Ponzoni Doxorubicin-loaded Fab′ fragments of anti-disialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude mice Cancer Res. 63 1 2003 86 92
17. O. Ishida, K. Maruyama, H. Tanahashi, M. Iwatsuru, K. Sasaki, M. Eriguchi, and H. Yanagie Liposomes bearing polyethyleneglycol-coupled transferrin with intracellular targeting property to the solid tumors in vivo Pharm. Res. 18 7 2001 1042 1048
18. V. Brower Tumor angiogenesis: new drugs on the block Nat. Biotechnol. 17 10 1999 963 968
19. B. St. Croix, C. Rago, V. Velculescu, G. Traverso, K.E. Romans, E. Montgomery, A. Lal, G.J. Riggins, C. Lengauer, B. Vogelstein, and K.W. Kinzler Genes expressed in human tumor endothelium Science 289 5494 2000 1197 1202
20. R.M. Schiffelers, G.A. Koning, T.L. ten Hagen, M.H. Fens, A.J. Schraa, A.P. Janssen, R.J. Kok, G. Molema, and G. Storm Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin J. Control. Release 91 1-2 2003 115 122
21. G. Bocci, K.C. Nicolaou, and R.S. Kerbel Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs Cancer Res. 62 23 2002 6938 6943
22. S. Man, G. Bocci, G. Francia, S.K. Green, S. Jothy, D. Hanahan, P. Bohlen, D.J. Hicklin, G. Bergers, and R.S. Kerbel Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water Cancer Res. 62 10 2002 2731 2735
23. P. Hahnfeldt, J. Folkman, and L. Hlatky Minimizing long-term tumor burden: the logic for metronomic chemotherapeutic dosing and its antiangiogenic basis J. Theor. Biol. 220 4 2003 545 554
24. F. Pastorino, C. Brignole, D. Marimpietri, M. Cilli, C. Gambini, D. Ribatti, R. Longhi, T.M. Allen, A. Corti, and M. Ponzoni Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy Cancer Res. 63 21 2003 7400 7409